• Vt. to get $1.1 million drug settlement
    November 17,2012
     

    MONTPELIER — Vermont’s attorney general says the state will receive $1.1 million as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company deceptively marketed a diabetes drug.

    The complaint accuses GlaxoSmithKline LLC of engaging in unfair and deceptive practices by misrepresenting Avandia’s cardiovascular risks and safety profile.

    Vermont Attorney General William Sorrell said Thursday that GlaxoSmithKline has reached a $90 million settlement with 37 other attorneys general and has agreed to change how it markets and promotes diabetes drugs.

    MORE IN This Just In
    NORTHFIELD — Forbes Magazine has given Norwich University a grade of ‘A'... Full Story
    MONTPELIER — A Burlington-based chain of drug-testing labs that has been a key player in... Full Story
    BARRE — A former employee of the Phoenix House recovery program has admitted to having sex with a... Full Story
    More Articles
  •  
     
    • MEDIA GALLERY 
    • VIDEOS
    • PHOTOS